Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa and Fludarabine in Chronic Lymphocytic Leukemia
NCT00281892Phase 3Completed
- Sponsor
- German CLL Study Group
- Start
- Sep 2004
- Primary completion
- May 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of darbepoetin alfa in chronic lymphocytic leukemia (CLL), anemia, sponsored by German CLL Study Group. Started Sep 2004; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
chronic lymphocytic leukemia (CLL)anemia
Beyond the preview
Go deeper on NCT00281892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281892.